Immunic Press Release
2020-08-20

Immunic, Inc. Announces Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function

Immunic, Inc. Announces Dosing of…
read more
Immunic Press Release
2020-08-20

Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Immunic, Inc. Announces Closing of…
read more
Immunic Press Release
2020-08-20

Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock

Immunic, Inc. Announces Pricing of…
read more
Fund+ Press Release
2020-07-28

Fund+ Establishes ExeVir Bio with VIB and UCB to Accelerate Development of New Treatment Conferring Broad Protection Against Covid-19

Fund+ Establishes ExeVir Bio with…
read more
Fund+ Press Release
2020-07-27

Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV

Fund+ Leads EUR38 Million Series…
read more
Aelin Therapeutics Press Release
2020-07-13

Aelin Therapeutics awarded €2.3 million VLAIO research grant

Aelin Therapeutics awarded €2.3 million…
read more
eTheRNA Press Release
2020-06-16

eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through toclinical proof of concept

eTheRNA raises EUR 34 million…
read more
Fund+ Press Release
2020-06-16

Fund+ Announces Investment in Ona Therapeutics EUR30 Million Series A financing

Fund+ Announces Investment in Ona…
read more
Immunic Press Release
2020-06-15

Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

Immunic, Inc. Announces First Patients…
read more
Fund+ Press Release
2020-06-15

Notable Board Changes

Notable Board Changes Fund+ Appoints…
read more